Uppsala Reports Long Reads – Ending the pregnant pause

Most women are prescribed some form of medication during their
pregnancy. Yet we know very little about the safety of those
medicines when they’re used during pregnancy or breastfeeding.
New collaborative efforts are now underway to plug that knowledge
gap.


This episode is part of the Uppsala Reports Long Reads series –
the most topical stories from UMC’s pharmacovigilance magazine,
brought to you in audio format. Find the text version here.

Tune in to find out:


Why clinical trials often fail to include pregnant and
breastfeeding women

What the lack of safety information means for women who need
medicines during pregnancy and breastfeeding

How new multi-disciplinary initiatives are planning to boost
pharmacovigilance activities related to pregnancy and lactation



Want to know more?


Read how EUROmediCAT plans to evaluate the safety of medicines in
pregnancy in relation to the risk of congenital anomalies. 


Find out how ConcePTION wants to help women make informed
decisions about the medications they need before, during and
after pregnancy.


Read about:


Lareb’s survey of pregnancy-related pharmacovigilance
activities

the history of women’s involvement in clinical trials

the ethical debate surrounding the inclusion of pregnant
women in research






Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.